These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 8536377)

  • 1. Functional activity of the membrane-associated complement inhibitor CD59 in a pig-to-human in vitro model for hyperacute xenograft rejection.
    Heckl-Ostreicher B; Binder R; Kirschfink M
    Clin Exp Immunol; 1995 Dec; 102(3):589-95. PubMed ID: 8536377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C5b-8 step lysis of swine endothelial cells by human complement and functional feature of transfected CD59.
    Miyagawa S; Mikata S; Shirakura R; Matsuda H; Nagasawa S; Terados A; Hatanaka M; Matsumoto M; Seya T
    Scand J Immunol; 1996 Apr; 43(4):361-6. PubMed ID: 8668913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of porcine aortic endothelial cells from complement-mediated cell lysis and activation by recombinant human CD59.
    Kennedy SP; Rollins SA; Burton WV; Sims PJ; Bothwell AL; Squinto SP; Zavoico GB
    Transplantation; 1994 May; 57(10):1494-501. PubMed ID: 7515200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of porcine endothelial cells from complement-mediated cytotoxicity by the human complement regulators CD59, C1 inhibitor, and soluble complement receptor type 1. Analysis in a pig-to-human in vitro model relevant to hyperacute xenograft rejection.
    Heckl-Ostreicher B; Wosnik A; Kirschfink M
    Transplantation; 1996 Dec; 62(11):1693-6. PubMed ID: 8970634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of xenogeneic cells from human complement-mediated lysis by the expression of human DAF, CD59 and MCP.
    Huang J; Gou D; Zhen C; Jiang D; Mao X; Li W; Chen S; Cai C
    FEMS Immunol Med Microbiol; 2001 Oct; 31(3):203-9. PubMed ID: 11720816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of human CD59 in transgenic pig organs enhances organ survival in an ex vivo xenogeneic perfusion model.
    Kroshus TJ; Bolman RM; Dalmasso AP; Rollins SA; Guilmette ER; Williams BL; Squinto SP; Fodor WL
    Transplantation; 1996 May; 61(10):1513-21. PubMed ID: 8633381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection.
    Fodor WL; Williams BL; Matis LA; Madri JA; Rollins SA; Knight JW; Velander W; Squinto SP
    Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11153-7. PubMed ID: 7526391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pig analogue of CD59 protects transgenic mouse hearts from injury by human complement.
    Fisicaro N; Aminian A; Hinchliffe SJ; Morgan BP; Pearse MJ; D'Apice AJ; Cowan PJ
    Transplantation; 2000 Sep; 70(6):963-8. PubMed ID: 11014650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role and regulation of pig CD59 and membrane cofactor protein/CD46 expressed on pig aortic endothelial cells.
    van den Berg CW; Rix C; Hanna SM; Perez de la Lastra JM; Morgan BP
    Transplantation; 2000 Aug; 70(4):667-73. PubMed ID: 10972227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal xenografts from triple-transgenic pigs are not hyperacutely rejected but cause coagulopathy in non-immunosuppressed baboons.
    Cowan PJ; Aminian A; Barlow H; Brown AA; Chen CG; Fisicaro N; Francis DM; Goodman DJ; Han W; Kurek M; Nottle MB; Pearse MJ; Salvaris E; Shinkel TA; Stainsby GV; Stewart AB; d'Apice AJ
    Transplantation; 2000 Jun; 69(12):2504-15. PubMed ID: 10910270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus early promoter induced expression of hCD59 in porcine organs provides protection against hyperacute rejection.
    Niemann H; Verhoeyen E; Wonigeit K; Lorenz R; Hecker J; Schwinzer R; Hauser H; Kues WA; Halter R; Lemme E; Herrmann D; Winkler M; Wirth D; Paul D
    Transplantation; 2001 Dec; 72(12):1898-906. PubMed ID: 11773886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of xenogeneic cardiac endothelium from human complement by expression of CD59 or DAF in transgenic mice.
    Byrne GW; McCurry KR; Kagan D; Quinn C; Martin MJ; Platt JL; Logan JS
    Transplantation; 1995 Nov; 60(10):1149-56. PubMed ID: 7482724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of complement-mediated swine endothelial cell lysis by a surface-bound form of human C4b binding protein.
    Mikata S; Miyagawa S; Iwata K; Nagasawa S; Hatanaka M; Matsumoto M; Kamiike W; Matsuda H; Shirakura R; Seya T
    Transplantation; 1998 Feb; 65(3):363-8. PubMed ID: 9484752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and functional characterization of a new gene encoding the mouse terminal complement inhibitor CD59.
    Qian YM; Qin X; Miwa T; Sun X; Halperin JA; Song WC
    J Immunol; 2000 Sep; 165(5):2528-34. PubMed ID: 10946279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the 5'HS4 sequence of the chicken beta-globin locus control region with human EF1 alpha gene promoter induces ubiquitous and high expression of human CD55 and CD59 cDNAs in transgenic rabbits.
    Taboit-Dameron F; Malassagne B; Viglietta C; Puissant C; Leroux-Coyau M; Chéreau C; Attal J; Weill B; Houdebine LM
    Transgenic Res; 1999 Jun; 8(3):223-35. PubMed ID: 10478492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of human CD55 and CD59 transgenic pigs and kidney xenotransplantation in the pig-to-baboon combination.
    Ménoret S; Plat M; Blancho G; Martinat-Botté F; Bernard P; Karam G; Tesson L; Renaudin K; Guillouet P; Weill B; Chéreau C; Houdebine LM; Soulillou JP; Terqui M; Anegon I
    Transplantation; 2004 May; 77(9):1468-71. PubMed ID: 15167611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated gene transfer of the triple human complement regulating proteins (DAF, CD59, MCP) in xenogeneic pig liver perfusion.
    Shiraishi M; Nagahama M; Nozato E; Oshiro T; Taira K; Muto Y
    Transplant Proc; 2000 Aug; 32(5):1116-7. PubMed ID: 10936387
    [No Abstract]   [Full Text] [Related]  

  • 18. Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complement-mediated damage.
    Byrne GW; McCurry KR; Martin MJ; McClellan SM; Platt JL; Logan JS
    Transplantation; 1997 Jan; 63(1):149-55. PubMed ID: 9000677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A human CD46 transgenic pig model system for the study of discordant xenotransplantation.
    Diamond LE; Quinn CM; Martin MJ; Lawson J; Platt JL; Logan JS
    Transplantation; 2001 Jan; 71(1):132-42. PubMed ID: 11211178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of hyperacute rejection in a model of orthotopic liver xenotransplantation from pig to baboon using polytransgenic pig livers (CD55, CD59, and H-transferase).
    Ramírez P; Montoya MJ; Ríos A; García Palenciano C; Majado M; Chávez R; Muñoz A; Fernández OM; Sánchez A; Segura B; Sansano T; Acosta F; Robles R; Sánchez F; Fuente T; Cascales P; González F; Ruiz D; Martínez L; Pons JA; Rodríguez JI; Yélamos J; Cowan P; d'Apice A; Parrilla P
    Transplant Proc; 2005 Nov; 37(9):4103-6. PubMed ID: 16386637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.